Diagnosis and management of pergolide-induced fibrosis

被引：39

作者：

Agarwal, P ^{[1
]}

Fahn, S ^{[1
]}

Frucht, SJ ^{[1
]}

机构：

[1] Columbia Presbyterian Med Ctr, Dept Neurol, Div Movement Disorders, New York, NY USA

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 06期

关键词：

pergolide; pleural fibrosis; retroperitoneal fibrosis; surgery;

D O I：

10.1002/mds.20200

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We report on 2 patients treated with pergolide, 1 of whom developed pleural fibrosis and the other retroperitoneal fibrosis. In both cases, an extensive diagnostic evaluation and surgical intervention were required to reach a diagnosis. Based on our experience with these patients and a review of cases of pergolide-induced fibrosis in the English-language literature, we propose guidelines for the diagnosis and management of this rare complication. (C) 2004 Movement Disorder Society.

引用

页码：699 / 704

页数：6

共 17 条

[1] Chronic pericardial constriction linked to the antiparkinsonian clopamine agonist pergolide [J].

Balachandran, KP ;

Stewart, D ;

Berg, GA ;

Oldroyd, KG .

POSTGRADUATE MEDICAL JOURNAL, 2002, 78 (915) :49-50

[2] PLEUROPULMONARY DISEASE ASSOCIATED WITH DOPAMINE AGONIST THERAPY [J].

BHATT, MH ;

KEENAN, SP ;

FLEETHAM, JA ;

CALNE, DB .

ANNALS OF NEUROLOGY, 1991, 30 (04) :613-616

[3] Pergolide-induced pleuropulmonary fibrosis [J].

Bleumink, GS ;

van der Molen-Eijgenraam, M ;

Strijbos, JH ;

Sanwikarja, S ;

van Puijenbroek, JP ;

Stricker, BHC .

CLINICAL NEUROPHARMACOLOGY, 2002, 25 (05) :290-293

[4]

CAMP GV, 2003, NEUROLOGY, V61, P859

[5] Pleuropulmonary disease due to pergolide use for restless legs syndrome [J].

Danoff, SK ;

Grasso, ME ;

Terry, PB ;

Flynn, JA .

CHEST, 2001, 120 (01) :313-316

[6] Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation [J].

Duffy, SM ;

Lawley, WJ ;

Kaur, D ;

Yang, WD ;

Bradding, P .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (05) :965-972

[7] The US Food and Drug Administration's registry of patients with pergolide-associated valuvular heart disease [J].

Flowers, CM ;

Racoosin, JA ;

Lu, SL ;

Beitz, JG .

MAYO CLINIC PROCEEDINGS, 2003, 78 (06) :730-731

[8]

HORVATH J, IN PESS MOV DISORD

[9] RETROPERITONEAL FIBROSIS IN A PATIENT WITH PARKINSONS-DISEASE TREATED WITH PERGOLIDE [J].

JIMENEZJIMENEZ, FJ ;

LOPEZALVAREZ, J ;

SANCHEZCHAPADO, M ;

MONTERO, E ;

MIQUEL, J ;

SIERRA, A ;

GUTIERREZ, F .

CLINICAL NEUROPHARMACOLOGY, 1995, 18 (03) :277-279

[10] Pergolide-induced lung disease in patients with Parkinson's disease [J].

Kastelik, JA ;

Aziz, I ;

Greenstone, MA ;

Thompson, R ;

Morice, AH .

RESPIRATORY MEDICINE, 2002, 96 (07) :548-550

← 1 2 →